Cerenome is trading 5.96% lower at $0.63, with healthcare-sector weakness adding pressure.
- The healthcare sector is down 1.48% amid policy uncertainty, while broader markets are mixed-to-higher.
- No fresh Cerenome-specific catalyst was identified for November 6; recent-session declines do not confirm a separate cause today.
- The Aetna coverage agreement announced November 4 does not establish a company-specific reason for todayβs decline.